Tuesday, January 26, 2021 5:15:45 AM
Laboratory testing - by which I assume from the context you mean in vitro testing - tells us little or nothing about the safety profile of a drug in vivo.
In reality we know from the limited information released from Phase II studies that even topically applied brilacidin is associated with some serious adverse events (see here, for example: https://clinicaltrials.gov/ct2/show/results/NCT02324335?term=brilacidin&draw=2&rank=1).
I suspect a full tabulation of the Adverse Events associated with brilacidin in all the human studies to date would be surprising to those who claim (in the face of the already available evidence to the contrary) that brilacidin is completely safe.
I also suspect that's one of the reasons that a deep-pocketed pharma company hasn't already snapped up what otherwise, from the little information in the public domain, looks like a very promising candidate.
If brilacidin were all Ehrlich claims, then there's any number of companies who would pay hundreds of millions upfront with more hundreds of millions in milestones.
Why haven't they?
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
"Nobody ever went broke underestimating the intelligence of the American public."
H. L. Mencken
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM